Frailty in end stage renal disease: Current perspectives
Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Nefrología (English Edition) |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251423000226 |
| _version_ | 1811164911346122752 |
|---|---|
| author | Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Ankur Gupta |
| author_facet | Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Ankur Gupta |
| author_sort | Shankar Prasad Nagaraju |
| collection | DOAJ |
| description | Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD. Resumen: La fragilidad es común en la enfermedad renal en etapa terminal (ESRD) y es un marcador de malos resultados. Su la prevalencia aumenta a medida que avanza la enfermedad renal crónica (ERC). Hay diferentes herramientas de medición disponibles para evaluar la fragilidad en la ERT. La patogenia de la fragilidad en la ESRD es multifactorial que incluye uremia y factores relacionados con la diálisis. En esta revisión actual, discutimos la importancia de la fragilidad, su patogénesis, métodos de cribado, implicaciones pronósticas y estrategias de manejo en el contexto de la ESRD. |
| first_indexed | 2024-04-10T15:29:59Z |
| format | Article |
| id | doaj.art-387d5a92e4804097b2efdd206da0b7dc |
| institution | Directory Open Access Journal |
| issn | 2013-2514 |
| language | English |
| last_indexed | 2024-04-10T15:29:59Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Nefrología (English Edition) |
| spelling | doaj.art-387d5a92e4804097b2efdd206da0b7dc2023-02-14T04:06:46ZengElsevierNefrología (English Edition)2013-25142022-09-01425531539Frailty in end stage renal disease: Current perspectivesShankar Prasad Nagaraju0Srinivas Vinayak Shenoy1Ankur Gupta2Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, IndiaDepartment of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, IndiaDepartment of Medicine, Whakatane Hospital, New Zealand; Corresponding author.Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD. Resumen: La fragilidad es común en la enfermedad renal en etapa terminal (ESRD) y es un marcador de malos resultados. Su la prevalencia aumenta a medida que avanza la enfermedad renal crónica (ERC). Hay diferentes herramientas de medición disponibles para evaluar la fragilidad en la ERT. La patogenia de la fragilidad en la ESRD es multifactorial que incluye uremia y factores relacionados con la diálisis. En esta revisión actual, discutimos la importancia de la fragilidad, su patogénesis, métodos de cribado, implicaciones pronósticas y estrategias de manejo en el contexto de la ESRD.http://www.sciencedirect.com/science/article/pii/S2013251423000226FragilidadEnfermedad renal en etapa terminalDiálisisSarcopeniaNefropatía senescente |
| spellingShingle | Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Ankur Gupta Frailty in end stage renal disease: Current perspectives Nefrología (English Edition) Fragilidad Enfermedad renal en etapa terminal Diálisis Sarcopenia Nefropatía senescente |
| title | Frailty in end stage renal disease: Current perspectives |
| title_full | Frailty in end stage renal disease: Current perspectives |
| title_fullStr | Frailty in end stage renal disease: Current perspectives |
| title_full_unstemmed | Frailty in end stage renal disease: Current perspectives |
| title_short | Frailty in end stage renal disease: Current perspectives |
| title_sort | frailty in end stage renal disease current perspectives |
| topic | Fragilidad Enfermedad renal en etapa terminal Diálisis Sarcopenia Nefropatía senescente |
| url | http://www.sciencedirect.com/science/article/pii/S2013251423000226 |
| work_keys_str_mv | AT shankarprasadnagaraju frailtyinendstagerenaldiseasecurrentperspectives AT srinivasvinayakshenoy frailtyinendstagerenaldiseasecurrentperspectives AT ankurgupta frailtyinendstagerenaldiseasecurrentperspectives |